Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: ALLY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on ALLY, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,563,322 ALLY shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,563,322 shares
    Change vs previous 13F -717,691 shares

    1.32% of the 13F portfolio, value $71,834,646.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,281,013 shares
    Change vs previous 13F -196,099 shares

    1.72% of the 13F portfolio, value $89,484,140.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,477,112 shares
    Change vs previous 13F -95,242 shares

    2.36% of the 13F portfolio, value $112,551,650.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,572,354 shares
    Change vs previous 13F -928,269 shares

    2.26% of the 13F portfolio, value $100,843,884.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,500,623 shares
    Change vs previous 13F +249,347 shares

    4.23% of the 13F portfolio, value $136,359,669.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,251,276 shares
    Change vs previous 13F +295,239 shares

    3.71% of the 13F portfolio, value $118,583,550.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,956,037 shares
    Change vs previous 13F +1,272,853 shares

    3.7% of the 13F portfolio, value $106,455,489.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,683,184 shares
    Change vs previous 13F not available

    2.08% of the 13F portfolio, value $59,908,836.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).